Date Filer Title Filing Type Shares Traded Price Total Held
Jun 03, 2024
CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 16,000 -- 48,245
Jun 03, 2024
CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 75,000 -- 75,000
Feb 15, 2024
CHIEF MEDICAL OFFICER
CHIEF MEDICAL OFFICER Form 4 Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 1,081 $1.27 31,487
Sep 18, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 20,000 -- 144,794
Sep 18, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 40,000 -- 40,000
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 120,000 -- 124,794
Feb 15, 2023
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 560,000 -- 560,000
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,000 -- --
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 5,000 -- --
Apr 23, 2021
Chief Medical Officer
Chief Medical Officer Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,210 -- --

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.